Measurement Strategy

Clinical Outcome Measurement Strategies That Drive Impact

In today’s competitive and patient-centric healthcare landscape, demonstrating the true value of medical products requires more than clinical efficacy—it demands robust, validated, and patient-centered outcome measurement strategies. At RTI-HS, we partner with life sciences organizations to design and implement clinical outcome assessments (COAs) that meet regulatory standards, resonate with patients, and support market access.

Our Strategic Approach

We offer end-to-end support for COA strategy development, including:

  • Literature and instrument reviews to guide COA selection and/or to determine that instrument modification or development is needed
  • Conceptual model development
  • Clinical trial design and consulting to optimize the analysis of COA data, as well as the value of results based on COA endpoints
  • Gap analysis of data supporting the use of COAs for your intended purpose
  • Collection of qualitative and quantitative data from patients, physicians, and other stakeholders
  • Advice on utility assessment strategies to support product value, including the identification of appropriate assessment methods, existing health state utility measures, and PRO instrument mapping algorithms

Download the whitepaper to learn about the types of data that may be collected during interviews with clinical trial participants and two approaches to conducting qualitative research in the clinical trial setting.

Featured Publications

Meet Our Experts